Matches in Wikidata for { <http://www.wikidata.org/entity/Q80352795> ?p ?o ?g. }
Showing items 1 to 48 of
48
with 100 items per page.
- Q80352795 description "article scientifique publié en 2004" @default.
- Q80352795 description "artículu científicu espublizáu en xunu de 2004" @default.
- Q80352795 description "scientific article published on 01 June 2004" @default.
- Q80352795 description "wetenschappelijk artikel" @default.
- Q80352795 description "наукова стаття, опублікована в червні 2004" @default.
- Q80352795 name "[Standards, options and recommendations for the use of recombinant erythropoietin (epoietin alpha and beta darbepoietin-alpha, EPO) in the management of anaemia in oncology for patient undergoing radiotherapy-update 2003]" @default.
- Q80352795 name "[Standards, options and recommendations for the use of recombinant erythropoietin (epoietin alpha and beta darbepoietin-alpha, EPO) in the management of anaemia in oncology for patient undergoing radiotherapy-update 2003]" @default.
- Q80352795 type Item @default.
- Q80352795 label "[Standards, options and recommendations for the use of recombinant erythropoietin (epoietin alpha and beta darbepoietin-alpha, EPO) in the management of anaemia in oncology for patient undergoing radiotherapy-update 2003]" @default.
- Q80352795 label "[Standards, options and recommendations for the use of recombinant erythropoietin (epoietin alpha and beta darbepoietin-alpha, EPO) in the management of anaemia in oncology for patient undergoing radiotherapy-update 2003]" @default.
- Q80352795 prefLabel "[Standards, options and recommendations for the use of recombinant erythropoietin (epoietin alpha and beta darbepoietin-alpha, EPO) in the management of anaemia in oncology for patient undergoing radiotherapy-update 2003]" @default.
- Q80352795 prefLabel "[Standards, options and recommendations for the use of recombinant erythropoietin (epoietin alpha and beta darbepoietin-alpha, EPO) in the management of anaemia in oncology for patient undergoing radiotherapy-update 2003]" @default.
- Q80352795 P1433 Q80352795-93417372-1C8A-4A1F-AAAB-4D12E3193CA8 @default.
- Q80352795 P1476 Q80352795-9D526981-C352-4390-8A5E-1BEB505C6649 @default.
- Q80352795 P2093 Q80352795-1389233B-571C-4488-A2C4-BD5CF0C626F2 @default.
- Q80352795 P2093 Q80352795-71F9F7D6-7E06-42F9-9219-5A061CA392A3 @default.
- Q80352795 P2093 Q80352795-798C3632-4CBA-4AD2-A60A-49084D9704C4 @default.
- Q80352795 P2093 Q80352795-B8BCAD96-8658-415E-80CB-6537A11D4FD7 @default.
- Q80352795 P2093 Q80352795-C84CC871-F8C8-4D15-9180-2E6FB8930081 @default.
- Q80352795 P2093 Q80352795-E23B7066-D389-4868-9846-1436D473E905 @default.
- Q80352795 P2093 Q80352795-F8CE8079-4E36-4A6A-B69D-F7D2A7818853 @default.
- Q80352795 P304 Q80352795-7DE414F5-AB19-44FA-AAE1-0150B8ED8C64 @default.
- Q80352795 P31 Q80352795-1E9AD3C3-112B-45BF-B97E-B52617468D9C @default.
- Q80352795 P356 Q80352795-A46B44D5-E70E-4596-A9E3-7D86DAE575CE @default.
- Q80352795 P433 Q80352795-4D4B5914-9A12-4ADB-BB2E-911AF692D7FE @default.
- Q80352795 P478 Q80352795-4419515F-08F9-439E-9B3B-FE9AA485C315 @default.
- Q80352795 P50 Q80352795-A9A7CF49-4D2C-49A2-808D-ADF286580FD2 @default.
- Q80352795 P577 Q80352795-1F6D0F82-C085-49F1-87DD-0C67E25080BA @default.
- Q80352795 P698 Q80352795-AA6489DD-1C15-444B-9EF5-A5DAD114B7A7 @default.
- Q80352795 P356 J.CANRAD.2004.04.001 @default.
- Q80352795 P698 15260007 @default.
- Q80352795 P1433 Q2585417 @default.
- Q80352795 P1476 "[Standards, options and recommendations for the use of recombinant erythropoietin (epoietin alpha and beta darbepoietin-alpha, EPO) in the management of anaemia in oncology for patient undergoing radiotherapy-update 2003]" @default.
- Q80352795 P2093 "Christian Marchal" @default.
- Q80352795 P2093 "Comité d'organisation des Standards, Options and Recommendations" @default.
- Q80352795 P2093 "Dominique Spaeth" @default.
- Q80352795 P2093 "Margaret Haugh" @default.
- Q80352795 P2093 "Nicolas Fabre" @default.
- Q80352795 P2093 "Nicole Casadevall" @default.
- Q80352795 P2093 "Perrine Marec-Berard" @default.
- Q80352795 P304 "197-206" @default.
- Q80352795 P31 Q13442814 @default.
- Q80352795 P356 "10.1016/J.CANRAD.2004.04.001" @default.
- Q80352795 P433 "3" @default.
- Q80352795 P478 "8" @default.
- Q80352795 P50 Q47818292 @default.
- Q80352795 P577 "2004-06-01T00:00:00Z" @default.
- Q80352795 P698 "15260007" @default.